WHO Warns of Dangers of Health Misinformation Across Social Media Following Elon Musk’s $44 bn Twitter Acquisition 27/04/2022 Raisa Santos Following the purchase of Twitter by billionaire Elon Musk on Monday, the World Health Organization warned about the dangers of health and vaccine misinformation on social media, and expressed hope that the acquisition would lead to an ‘improvement of quality information’. “There is misinformation and disinformation out there across whatever platform you wish to go […] Continue reading -> WHO Supports DRC with Ebola Outbreak and Continues Investigation of Unexplained Acute Hepatitis Cases in US and Europe 27/04/2022 Raisa Santos The World Health Organization has announced an outbreak of Ebola in the Democratic Republic of Congo and its continued investigation of almost 200 cases of unexplained acute hepatitis in the US and Europe in a media briefing Tuesday afternoon. Two cases of Ebola have been confirmed in the northwestern Democratic Republic of Congo, prompting health […] Continue reading -> Lack of COVID-19 Testing is Undermining Global Tracking – And Uptake of the New Antiviral Drugs 26/04/2022 Kerry Cullinan & Raisa Santos The precipitous drop in COVID-19 testing across the world since January has made it harder to track the evolution of variants, and is also undermining the potential of new antiviral drugs that have to be taken early to be effective. Testing was a major focus of Tuesday’s meeting of the Access to COVID Tools Accelerator […] Continue reading -> Drug-Resistant Infections Kill More Newborns as Doctors Run Out of Treatment Options 26/04/2022 Kerry Cullinan More newborn babies with sepsis are dying because their infections are not responding to the usual antibiotics, according to the biggest global study on the subject yet. The study’s sponsor, the Global Antibiotic Research and Development Partnership (GARDP), is now designing an interventional trial to identify better treatment regimens. to combat rising resistance. GARDP’s study, […] Continue reading -> Malaria, Polio, and COVID-19: Lessons for Existing and Future Pandemics 26/04/2022 Sarthak Das, Aidan O’Leary & Shekhar Mehta On the occasion of World Immunization Week, influential global health figures share lessons learned in the global fight against two age-old diseases, malaria and polio – and more recently, COVID-19 – and how we should tackle existing and future pandemics. While COVID-19 surprised and shocked the world, it should not have. For decades, infectious […] Continue reading -> The Dilemma of Vaccine ‘Charity’ vs Building Africa’s Production Capacity 25/04/2022 Kerry Cullinan CAPE TOWN – As the health sector celebrates World Immunisation Week, one of the most pressing related problems is Africa’s almost total dependence on imported vaccines – something that predates, but was highlighted by, the COVID-19 pandemic. But addressing this dependence will mean dismantling the ‘charity’ model that has underpinned many of Africa’s immunisation programmes […] Continue reading -> J&J Teams up with African Centre to Find New Drugs to Address Antimicrobial Resistance 25/04/2022 Kerry Cullinan CAPE TOWN – A new partnership between African scientists and pharmaceutical company Johnson & Johnson (J&J), aimed at finding solutions to antimicrobial resistance (AMR), was launched in South Africa on Monday. The J&J Satellite Center for Global Health Discovery, housed at the University of Cape Town (UCT)’s Holistic Drug Discovery and Development (H3D) Center, will […] Continue reading -> WHO and Pfizer Concerned About Access to New COVID Antiviral Paxlovid – But For Different Reasons 22/04/2022 Kerry Cullinan The World Health Organization (WHO) has recommended Paxlovid, the antiviral medicine produced by Pfizer, for patients with COVID-19 at high risk of developing severe disease – but it is concerned about limited access to the life-saving medicine. Friday’s WHO recommendation is aimed at “patients with non-severe COVID-19 who are at highest risk of developing severe […] Continue reading -> Finding Legal and Financial Pathways for Universal Health Coverage Should Be at the Heart of a Pandemic Treaty 22/04/2022 Elaine Ruth Fletcher Discussions about the creation of a new global convention on pandemic preparedness and response have already become a bit like a Christmas tree. Last week’s WHO-convened public hearings, saw a wide array of interest groups trying to attach a number of features to the proposed international pandemic instrument, ranging from stronger accountability and transparency measures […] Continue reading -> Could Mysterious Hepatitis Cases be Triggered by COVID-19? 21/04/2022 Maayan Hoffman More than 100 mysterious cases of hepatitis in children under the age of 10 around the world are raising a red flag among the medical community, with some doctors and scientists starting to hypothesise that the cases could be triggered by a new strain of adenovirus or even COVID-19. “Severe hepatitis in children is very […] Continue reading -> Posts navigation Older postsNewer posts
WHO Supports DRC with Ebola Outbreak and Continues Investigation of Unexplained Acute Hepatitis Cases in US and Europe 27/04/2022 Raisa Santos The World Health Organization has announced an outbreak of Ebola in the Democratic Republic of Congo and its continued investigation of almost 200 cases of unexplained acute hepatitis in the US and Europe in a media briefing Tuesday afternoon. Two cases of Ebola have been confirmed in the northwestern Democratic Republic of Congo, prompting health […] Continue reading -> Lack of COVID-19 Testing is Undermining Global Tracking – And Uptake of the New Antiviral Drugs 26/04/2022 Kerry Cullinan & Raisa Santos The precipitous drop in COVID-19 testing across the world since January has made it harder to track the evolution of variants, and is also undermining the potential of new antiviral drugs that have to be taken early to be effective. Testing was a major focus of Tuesday’s meeting of the Access to COVID Tools Accelerator […] Continue reading -> Drug-Resistant Infections Kill More Newborns as Doctors Run Out of Treatment Options 26/04/2022 Kerry Cullinan More newborn babies with sepsis are dying because their infections are not responding to the usual antibiotics, according to the biggest global study on the subject yet. The study’s sponsor, the Global Antibiotic Research and Development Partnership (GARDP), is now designing an interventional trial to identify better treatment regimens. to combat rising resistance. GARDP’s study, […] Continue reading -> Malaria, Polio, and COVID-19: Lessons for Existing and Future Pandemics 26/04/2022 Sarthak Das, Aidan O’Leary & Shekhar Mehta On the occasion of World Immunization Week, influential global health figures share lessons learned in the global fight against two age-old diseases, malaria and polio – and more recently, COVID-19 – and how we should tackle existing and future pandemics. While COVID-19 surprised and shocked the world, it should not have. For decades, infectious […] Continue reading -> The Dilemma of Vaccine ‘Charity’ vs Building Africa’s Production Capacity 25/04/2022 Kerry Cullinan CAPE TOWN – As the health sector celebrates World Immunisation Week, one of the most pressing related problems is Africa’s almost total dependence on imported vaccines – something that predates, but was highlighted by, the COVID-19 pandemic. But addressing this dependence will mean dismantling the ‘charity’ model that has underpinned many of Africa’s immunisation programmes […] Continue reading -> J&J Teams up with African Centre to Find New Drugs to Address Antimicrobial Resistance 25/04/2022 Kerry Cullinan CAPE TOWN – A new partnership between African scientists and pharmaceutical company Johnson & Johnson (J&J), aimed at finding solutions to antimicrobial resistance (AMR), was launched in South Africa on Monday. The J&J Satellite Center for Global Health Discovery, housed at the University of Cape Town (UCT)’s Holistic Drug Discovery and Development (H3D) Center, will […] Continue reading -> WHO and Pfizer Concerned About Access to New COVID Antiviral Paxlovid – But For Different Reasons 22/04/2022 Kerry Cullinan The World Health Organization (WHO) has recommended Paxlovid, the antiviral medicine produced by Pfizer, for patients with COVID-19 at high risk of developing severe disease – but it is concerned about limited access to the life-saving medicine. Friday’s WHO recommendation is aimed at “patients with non-severe COVID-19 who are at highest risk of developing severe […] Continue reading -> Finding Legal and Financial Pathways for Universal Health Coverage Should Be at the Heart of a Pandemic Treaty 22/04/2022 Elaine Ruth Fletcher Discussions about the creation of a new global convention on pandemic preparedness and response have already become a bit like a Christmas tree. Last week’s WHO-convened public hearings, saw a wide array of interest groups trying to attach a number of features to the proposed international pandemic instrument, ranging from stronger accountability and transparency measures […] Continue reading -> Could Mysterious Hepatitis Cases be Triggered by COVID-19? 21/04/2022 Maayan Hoffman More than 100 mysterious cases of hepatitis in children under the age of 10 around the world are raising a red flag among the medical community, with some doctors and scientists starting to hypothesise that the cases could be triggered by a new strain of adenovirus or even COVID-19. “Severe hepatitis in children is very […] Continue reading -> Posts navigation Older postsNewer posts
Lack of COVID-19 Testing is Undermining Global Tracking – And Uptake of the New Antiviral Drugs 26/04/2022 Kerry Cullinan & Raisa Santos The precipitous drop in COVID-19 testing across the world since January has made it harder to track the evolution of variants, and is also undermining the potential of new antiviral drugs that have to be taken early to be effective. Testing was a major focus of Tuesday’s meeting of the Access to COVID Tools Accelerator […] Continue reading -> Drug-Resistant Infections Kill More Newborns as Doctors Run Out of Treatment Options 26/04/2022 Kerry Cullinan More newborn babies with sepsis are dying because their infections are not responding to the usual antibiotics, according to the biggest global study on the subject yet. The study’s sponsor, the Global Antibiotic Research and Development Partnership (GARDP), is now designing an interventional trial to identify better treatment regimens. to combat rising resistance. GARDP’s study, […] Continue reading -> Malaria, Polio, and COVID-19: Lessons for Existing and Future Pandemics 26/04/2022 Sarthak Das, Aidan O’Leary & Shekhar Mehta On the occasion of World Immunization Week, influential global health figures share lessons learned in the global fight against two age-old diseases, malaria and polio – and more recently, COVID-19 – and how we should tackle existing and future pandemics. While COVID-19 surprised and shocked the world, it should not have. For decades, infectious […] Continue reading -> The Dilemma of Vaccine ‘Charity’ vs Building Africa’s Production Capacity 25/04/2022 Kerry Cullinan CAPE TOWN – As the health sector celebrates World Immunisation Week, one of the most pressing related problems is Africa’s almost total dependence on imported vaccines – something that predates, but was highlighted by, the COVID-19 pandemic. But addressing this dependence will mean dismantling the ‘charity’ model that has underpinned many of Africa’s immunisation programmes […] Continue reading -> J&J Teams up with African Centre to Find New Drugs to Address Antimicrobial Resistance 25/04/2022 Kerry Cullinan CAPE TOWN – A new partnership between African scientists and pharmaceutical company Johnson & Johnson (J&J), aimed at finding solutions to antimicrobial resistance (AMR), was launched in South Africa on Monday. The J&J Satellite Center for Global Health Discovery, housed at the University of Cape Town (UCT)’s Holistic Drug Discovery and Development (H3D) Center, will […] Continue reading -> WHO and Pfizer Concerned About Access to New COVID Antiviral Paxlovid – But For Different Reasons 22/04/2022 Kerry Cullinan The World Health Organization (WHO) has recommended Paxlovid, the antiviral medicine produced by Pfizer, for patients with COVID-19 at high risk of developing severe disease – but it is concerned about limited access to the life-saving medicine. Friday’s WHO recommendation is aimed at “patients with non-severe COVID-19 who are at highest risk of developing severe […] Continue reading -> Finding Legal and Financial Pathways for Universal Health Coverage Should Be at the Heart of a Pandemic Treaty 22/04/2022 Elaine Ruth Fletcher Discussions about the creation of a new global convention on pandemic preparedness and response have already become a bit like a Christmas tree. Last week’s WHO-convened public hearings, saw a wide array of interest groups trying to attach a number of features to the proposed international pandemic instrument, ranging from stronger accountability and transparency measures […] Continue reading -> Could Mysterious Hepatitis Cases be Triggered by COVID-19? 21/04/2022 Maayan Hoffman More than 100 mysterious cases of hepatitis in children under the age of 10 around the world are raising a red flag among the medical community, with some doctors and scientists starting to hypothesise that the cases could be triggered by a new strain of adenovirus or even COVID-19. “Severe hepatitis in children is very […] Continue reading -> Posts navigation Older postsNewer posts
Drug-Resistant Infections Kill More Newborns as Doctors Run Out of Treatment Options 26/04/2022 Kerry Cullinan More newborn babies with sepsis are dying because their infections are not responding to the usual antibiotics, according to the biggest global study on the subject yet. The study’s sponsor, the Global Antibiotic Research and Development Partnership (GARDP), is now designing an interventional trial to identify better treatment regimens. to combat rising resistance. GARDP’s study, […] Continue reading -> Malaria, Polio, and COVID-19: Lessons for Existing and Future Pandemics 26/04/2022 Sarthak Das, Aidan O’Leary & Shekhar Mehta On the occasion of World Immunization Week, influential global health figures share lessons learned in the global fight against two age-old diseases, malaria and polio – and more recently, COVID-19 – and how we should tackle existing and future pandemics. While COVID-19 surprised and shocked the world, it should not have. For decades, infectious […] Continue reading -> The Dilemma of Vaccine ‘Charity’ vs Building Africa’s Production Capacity 25/04/2022 Kerry Cullinan CAPE TOWN – As the health sector celebrates World Immunisation Week, one of the most pressing related problems is Africa’s almost total dependence on imported vaccines – something that predates, but was highlighted by, the COVID-19 pandemic. But addressing this dependence will mean dismantling the ‘charity’ model that has underpinned many of Africa’s immunisation programmes […] Continue reading -> J&J Teams up with African Centre to Find New Drugs to Address Antimicrobial Resistance 25/04/2022 Kerry Cullinan CAPE TOWN – A new partnership between African scientists and pharmaceutical company Johnson & Johnson (J&J), aimed at finding solutions to antimicrobial resistance (AMR), was launched in South Africa on Monday. The J&J Satellite Center for Global Health Discovery, housed at the University of Cape Town (UCT)’s Holistic Drug Discovery and Development (H3D) Center, will […] Continue reading -> WHO and Pfizer Concerned About Access to New COVID Antiviral Paxlovid – But For Different Reasons 22/04/2022 Kerry Cullinan The World Health Organization (WHO) has recommended Paxlovid, the antiviral medicine produced by Pfizer, for patients with COVID-19 at high risk of developing severe disease – but it is concerned about limited access to the life-saving medicine. Friday’s WHO recommendation is aimed at “patients with non-severe COVID-19 who are at highest risk of developing severe […] Continue reading -> Finding Legal and Financial Pathways for Universal Health Coverage Should Be at the Heart of a Pandemic Treaty 22/04/2022 Elaine Ruth Fletcher Discussions about the creation of a new global convention on pandemic preparedness and response have already become a bit like a Christmas tree. Last week’s WHO-convened public hearings, saw a wide array of interest groups trying to attach a number of features to the proposed international pandemic instrument, ranging from stronger accountability and transparency measures […] Continue reading -> Could Mysterious Hepatitis Cases be Triggered by COVID-19? 21/04/2022 Maayan Hoffman More than 100 mysterious cases of hepatitis in children under the age of 10 around the world are raising a red flag among the medical community, with some doctors and scientists starting to hypothesise that the cases could be triggered by a new strain of adenovirus or even COVID-19. “Severe hepatitis in children is very […] Continue reading -> Posts navigation Older postsNewer posts
Malaria, Polio, and COVID-19: Lessons for Existing and Future Pandemics 26/04/2022 Sarthak Das, Aidan O’Leary & Shekhar Mehta On the occasion of World Immunization Week, influential global health figures share lessons learned in the global fight against two age-old diseases, malaria and polio – and more recently, COVID-19 – and how we should tackle existing and future pandemics. While COVID-19 surprised and shocked the world, it should not have. For decades, infectious […] Continue reading -> The Dilemma of Vaccine ‘Charity’ vs Building Africa’s Production Capacity 25/04/2022 Kerry Cullinan CAPE TOWN – As the health sector celebrates World Immunisation Week, one of the most pressing related problems is Africa’s almost total dependence on imported vaccines – something that predates, but was highlighted by, the COVID-19 pandemic. But addressing this dependence will mean dismantling the ‘charity’ model that has underpinned many of Africa’s immunisation programmes […] Continue reading -> J&J Teams up with African Centre to Find New Drugs to Address Antimicrobial Resistance 25/04/2022 Kerry Cullinan CAPE TOWN – A new partnership between African scientists and pharmaceutical company Johnson & Johnson (J&J), aimed at finding solutions to antimicrobial resistance (AMR), was launched in South Africa on Monday. The J&J Satellite Center for Global Health Discovery, housed at the University of Cape Town (UCT)’s Holistic Drug Discovery and Development (H3D) Center, will […] Continue reading -> WHO and Pfizer Concerned About Access to New COVID Antiviral Paxlovid – But For Different Reasons 22/04/2022 Kerry Cullinan The World Health Organization (WHO) has recommended Paxlovid, the antiviral medicine produced by Pfizer, for patients with COVID-19 at high risk of developing severe disease – but it is concerned about limited access to the life-saving medicine. Friday’s WHO recommendation is aimed at “patients with non-severe COVID-19 who are at highest risk of developing severe […] Continue reading -> Finding Legal and Financial Pathways for Universal Health Coverage Should Be at the Heart of a Pandemic Treaty 22/04/2022 Elaine Ruth Fletcher Discussions about the creation of a new global convention on pandemic preparedness and response have already become a bit like a Christmas tree. Last week’s WHO-convened public hearings, saw a wide array of interest groups trying to attach a number of features to the proposed international pandemic instrument, ranging from stronger accountability and transparency measures […] Continue reading -> Could Mysterious Hepatitis Cases be Triggered by COVID-19? 21/04/2022 Maayan Hoffman More than 100 mysterious cases of hepatitis in children under the age of 10 around the world are raising a red flag among the medical community, with some doctors and scientists starting to hypothesise that the cases could be triggered by a new strain of adenovirus or even COVID-19. “Severe hepatitis in children is very […] Continue reading -> Posts navigation Older postsNewer posts
The Dilemma of Vaccine ‘Charity’ vs Building Africa’s Production Capacity 25/04/2022 Kerry Cullinan CAPE TOWN – As the health sector celebrates World Immunisation Week, one of the most pressing related problems is Africa’s almost total dependence on imported vaccines – something that predates, but was highlighted by, the COVID-19 pandemic. But addressing this dependence will mean dismantling the ‘charity’ model that has underpinned many of Africa’s immunisation programmes […] Continue reading -> J&J Teams up with African Centre to Find New Drugs to Address Antimicrobial Resistance 25/04/2022 Kerry Cullinan CAPE TOWN – A new partnership between African scientists and pharmaceutical company Johnson & Johnson (J&J), aimed at finding solutions to antimicrobial resistance (AMR), was launched in South Africa on Monday. The J&J Satellite Center for Global Health Discovery, housed at the University of Cape Town (UCT)’s Holistic Drug Discovery and Development (H3D) Center, will […] Continue reading -> WHO and Pfizer Concerned About Access to New COVID Antiviral Paxlovid – But For Different Reasons 22/04/2022 Kerry Cullinan The World Health Organization (WHO) has recommended Paxlovid, the antiviral medicine produced by Pfizer, for patients with COVID-19 at high risk of developing severe disease – but it is concerned about limited access to the life-saving medicine. Friday’s WHO recommendation is aimed at “patients with non-severe COVID-19 who are at highest risk of developing severe […] Continue reading -> Finding Legal and Financial Pathways for Universal Health Coverage Should Be at the Heart of a Pandemic Treaty 22/04/2022 Elaine Ruth Fletcher Discussions about the creation of a new global convention on pandemic preparedness and response have already become a bit like a Christmas tree. Last week’s WHO-convened public hearings, saw a wide array of interest groups trying to attach a number of features to the proposed international pandemic instrument, ranging from stronger accountability and transparency measures […] Continue reading -> Could Mysterious Hepatitis Cases be Triggered by COVID-19? 21/04/2022 Maayan Hoffman More than 100 mysterious cases of hepatitis in children under the age of 10 around the world are raising a red flag among the medical community, with some doctors and scientists starting to hypothesise that the cases could be triggered by a new strain of adenovirus or even COVID-19. “Severe hepatitis in children is very […] Continue reading -> Posts navigation Older postsNewer posts
J&J Teams up with African Centre to Find New Drugs to Address Antimicrobial Resistance 25/04/2022 Kerry Cullinan CAPE TOWN – A new partnership between African scientists and pharmaceutical company Johnson & Johnson (J&J), aimed at finding solutions to antimicrobial resistance (AMR), was launched in South Africa on Monday. The J&J Satellite Center for Global Health Discovery, housed at the University of Cape Town (UCT)’s Holistic Drug Discovery and Development (H3D) Center, will […] Continue reading -> WHO and Pfizer Concerned About Access to New COVID Antiviral Paxlovid – But For Different Reasons 22/04/2022 Kerry Cullinan The World Health Organization (WHO) has recommended Paxlovid, the antiviral medicine produced by Pfizer, for patients with COVID-19 at high risk of developing severe disease – but it is concerned about limited access to the life-saving medicine. Friday’s WHO recommendation is aimed at “patients with non-severe COVID-19 who are at highest risk of developing severe […] Continue reading -> Finding Legal and Financial Pathways for Universal Health Coverage Should Be at the Heart of a Pandemic Treaty 22/04/2022 Elaine Ruth Fletcher Discussions about the creation of a new global convention on pandemic preparedness and response have already become a bit like a Christmas tree. Last week’s WHO-convened public hearings, saw a wide array of interest groups trying to attach a number of features to the proposed international pandemic instrument, ranging from stronger accountability and transparency measures […] Continue reading -> Could Mysterious Hepatitis Cases be Triggered by COVID-19? 21/04/2022 Maayan Hoffman More than 100 mysterious cases of hepatitis in children under the age of 10 around the world are raising a red flag among the medical community, with some doctors and scientists starting to hypothesise that the cases could be triggered by a new strain of adenovirus or even COVID-19. “Severe hepatitis in children is very […] Continue reading -> Posts navigation Older postsNewer posts
WHO and Pfizer Concerned About Access to New COVID Antiviral Paxlovid – But For Different Reasons 22/04/2022 Kerry Cullinan The World Health Organization (WHO) has recommended Paxlovid, the antiviral medicine produced by Pfizer, for patients with COVID-19 at high risk of developing severe disease – but it is concerned about limited access to the life-saving medicine. Friday’s WHO recommendation is aimed at “patients with non-severe COVID-19 who are at highest risk of developing severe […] Continue reading -> Finding Legal and Financial Pathways for Universal Health Coverage Should Be at the Heart of a Pandemic Treaty 22/04/2022 Elaine Ruth Fletcher Discussions about the creation of a new global convention on pandemic preparedness and response have already become a bit like a Christmas tree. Last week’s WHO-convened public hearings, saw a wide array of interest groups trying to attach a number of features to the proposed international pandemic instrument, ranging from stronger accountability and transparency measures […] Continue reading -> Could Mysterious Hepatitis Cases be Triggered by COVID-19? 21/04/2022 Maayan Hoffman More than 100 mysterious cases of hepatitis in children under the age of 10 around the world are raising a red flag among the medical community, with some doctors and scientists starting to hypothesise that the cases could be triggered by a new strain of adenovirus or even COVID-19. “Severe hepatitis in children is very […] Continue reading -> Posts navigation Older postsNewer posts
Finding Legal and Financial Pathways for Universal Health Coverage Should Be at the Heart of a Pandemic Treaty 22/04/2022 Elaine Ruth Fletcher Discussions about the creation of a new global convention on pandemic preparedness and response have already become a bit like a Christmas tree. Last week’s WHO-convened public hearings, saw a wide array of interest groups trying to attach a number of features to the proposed international pandemic instrument, ranging from stronger accountability and transparency measures […] Continue reading -> Could Mysterious Hepatitis Cases be Triggered by COVID-19? 21/04/2022 Maayan Hoffman More than 100 mysterious cases of hepatitis in children under the age of 10 around the world are raising a red flag among the medical community, with some doctors and scientists starting to hypothesise that the cases could be triggered by a new strain of adenovirus or even COVID-19. “Severe hepatitis in children is very […] Continue reading -> Posts navigation Older postsNewer posts
Could Mysterious Hepatitis Cases be Triggered by COVID-19? 21/04/2022 Maayan Hoffman More than 100 mysterious cases of hepatitis in children under the age of 10 around the world are raising a red flag among the medical community, with some doctors and scientists starting to hypothesise that the cases could be triggered by a new strain of adenovirus or even COVID-19. “Severe hepatitis in children is very […] Continue reading -> Posts navigation Older postsNewer posts